Results
Bharat Parenterals Q1 FY27 Revenue Down 19% YoY
Bharat Parenterals reported Q1 FY27 consolidated revenue of ₹93.7 Cr, down 19.2% YoY, with PAT at ₹(3.6) Cr.
Subsidiaries Innoxel (+165% YoY) and Varenyam Healthcare (+52% YoY) now contribute 46% of c
